Spinal News International e-newsletter

Главная  /  Новости  /  Spinal News International e-newsletter
Click here to view web version
Spinal News
Friday, 02 February 2018  

Home | Videos | Past issues | Subscribe | Contact us


Top stories


Johnson & Johnson merges global healthcare education programmes

Johnson & Johnson has formed the Johnson & Johnson Institute, bringing together 26 professional educational facilities across four continents. It includes a network of online education and partnerships across multiple specialties.


State-of-the-art technique may help to identify cervical radiculopathy patients requiring surgery

New research using unbiased serum proteomics, a state-of-the-art technique in orthopaedics, aims to predict which cervical radiculopathy patients will fail conservative treatment and consequently require surgery.



Case report images

Case report: Successful lumbar interbody fusion with PEEK-OPTIMA™ HA Enhanced cage and autograft for severe stenosis in a geriatric patient

In this case a 76-year-old female patient presented with severe stenosis and subluxation and was taking oxycodone twice daily for leg, bilateral hip and posterior thigh pain and rated between 4 and 10 by Visual Analog Scale (VAS). 

Product News


Kleiner Device Labs announces full commercial availability of a new spinal bone graft delivery tool

Kleiner Device Labs has announced full commercial availability of a new spinal bone graft delivery tool, the KG 1, featuring a patented design that facilitates less-invasive procedures and has been proven in clinical testing to reduce spinal fusion failure rates by 68%.


Life Spine announces sales growth of ProLift Expandable Spacer System for 2017

Life Spine have announced that revenues for ProLift Expandable Spacer System grew by 493% for 2017 as compared to 2016. According to Life Spine, ProLift continues the company’s commitment of offering innovative Micro-Invasive procedural solutions to better improve patients’ lives.


Spineology completes first lateral post-market study cases using novel implant design

Spineology has announced the completion of the first post-market study cases using its recently FDA-cleared Duo Lumbar Interbody Fusion System. In October, the company announced the initiation of this prospective, post-market lateral interbody fusion study designed to evaluate patient outcomes.

Write to us:

Editor: Suzie Marshall - suzie@bibamedical.com

Advertise with us:

Elizabeth Sutherst - elizabeth@bibamedical.com

You are receiving this email because you subscribed/registered on www.spinalnewsinternational.com

Our mailing address is:
BIBA Medical Ltd, 526 Fulham Road, Fulham, London, SW6 5NR 
TEL: +44 (0)20 7736 8788 
FAX: +44 (0)20 7736 8283 
EMAIL: info@bibamedical.com

© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429. VAT registration number 730 6811 50